person

Angela I. C.

Country
Spain
Department
Psychiatry

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
29
Sites with multiple studies

Has run more than one trial at 29 of 144 partner sites.

Specializations

Oncology

Clinical research activity includes a strong focus on solid tumours and haematologic malignancies, with particular involvement in breast cancer, lung cancer, urothelial carcinoma, ovarian cancer, and colorectal cancer.

  • Advanced and metastatic solid tumours
  • Breast cancer subtypes
  • Lung cancer
  • Urothelial and gastrointestinal cancers
  • Lymphoma and myeloma

Interest also extends to targeted therapy, immuno-oncology, and treatment selection in difficult-to-treat cancer settings.

Neuropsychiatry

As a specialist in Psychiatry, the investigator is involved in studies addressing major depressive disorder, schizophrenia, and obsessive compulsive disorder, alongside broader work in neuropsychiatric symptom control.

  • Major depressive disorder
  • Schizophrenia
  • Obsessive compulsive disorder
  • Parkinson’s disease-related symptoms
  • Huntington’s disease

This area also includes clinical interest in cognitive and behavioural disorders with unmet therapeutic need.

Autoimmune and inflammatory disease

The research portfolio includes multiple immune-mediated conditions, with activity in systemic lupus erythematosus, rheumatoid arthritis, juvenile idiopathic arthritis, Sjögren’s disease, and myasthenia gravis.

  • Systemic lupus erythematosus
  • Rheumatoid arthritis
  • Juvenile idiopathic arthritis
  • Sjögren’s disease
  • Myasthenia gravis

Additional involvement covers bullous pemphigoid, vitiligo, psoriasis, and other chronic inflammatory disorders.

Cardiometabolic and vascular disease

Research interest also includes atherosclerotic cardiovascular disease, heart failure, myocardial infarction, stroke, and atrial fibrillation, reflecting work across major vascular risk and event prevention domains.

  • Atherosclerotic cardiovascular disease
  • Heart failure
  • Myocardial infarction
  • Stroke prevention
  • Dyslipidemia and obesity

Therapeutic interest further includes cardiometabolic risk reduction and management of metabolic disease.

Hepatic, renal, and respiratory disorders

The investigator is also linked to studies in chronic liver disease, cirrhosis, hepatocellular carcinoma, chronic kidney disease, IgA nephropathy, and asthma.

  • Chronic liver disease and cirrhosis
  • Hepatocellular carcinoma
  • Chronic kidney disease
  • IgA nephropathy
  • Asthma and allergic airway disease

These areas include therapeutic interest in organ failure syndromes, fibroinflammatory disease, and chronic respiratory inflammation.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.